EMP-01

N/A

Report date: 2024/11/20 20:00:31
NME

Base Information

Drug NameEMP-01
Drug Alias NameEMP-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticPhobia, Social
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtai Life Sciences NVEmpathBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtai Therapeutics IncEmpathBio Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticPhobia, Social
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A